» Articles » PMID: 24721648

Cardiac and Renal Inward Rectifier Potassium Channel Pharmacology: Emerging Tools for Integrative Physiology and Therapeutics

Overview
Specialty Pharmacology
Date 2014 Apr 12
PMID 24721648
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Inward rectifier potassium (Kir) channels play fundamental roles in cardiac and renal function and may represent unexploited drug targets for cardiovascular diseases. However, the limited pharmacology of Kir channels has slowed progress toward exploring their integrative physiology and therapeutic potential. Here, we review recent progress toward developing the small-molecule pharmacology for Kir2.x, Kir4.1, and Kir7.1 and discuss common mechanistic themes that may help guide future Kir channel-directed drug discovery efforts.

Citing Articles

The key mediator of diabetic kidney disease: Potassium channel dysfunction.

Guo J, Zhang C, Zhao H, Yan Y, Liu Z Genes Dis. 2024; 11(4):101119.

PMID: 38523672 PMC: 10958065. DOI: 10.1016/j.gendis.2023.101119.


Special collection on inward rectifying K channels.

Denton J, Delpire E Am J Physiol Cell Physiol. 2023; 324(3):C603-C605.

PMID: 36689674 PMC: 9942886. DOI: 10.1152/ajpcell.00457.2022.


VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium Channels.

McClenahan S, Kent C, Kharade S, Isaeva E, Williams J, Han C Mol Pharmacol. 2022; 101(5):357-370.

PMID: 35246480 PMC: 9092466. DOI: 10.1124/molpharm.121.000464.


Next-generation inward rectifier potassium channel modulators: discovery and molecular pharmacology.

Weaver C, Denton J Am J Physiol Cell Physiol. 2021; 320(6):C1125-C1140.

PMID: 33826405 PMC: 8285633. DOI: 10.1152/ajpcell.00548.2020.


Kir4.1/Kir5.1 channels possess strong intrinsic inward rectification determined by a voltage-dependent K+-flux gating mechanism.

Marmolejo-Murillo L, Arechiga-Figueroa I, Moreno-Galindo E, Ferrer T, Zamora-Cardenas R, Navarro-Polanco R J Gen Physiol. 2021; 153(5).

PMID: 33822868 PMC: 8025212. DOI: 10.1085/jgp.201912540.


References
1.
Lopez-Izquierdo A, Ponce-Balbuena D, Ferrer T, Rodriguez-Menchaca A, Sanchez-Chapula J . Thiopental inhibits function of different inward rectifying potassium channel isoforms by a similar mechanism. Eur J Pharmacol. 2010; 638(1-3):33-41. DOI: 10.1016/j.ejphar.2010.04.026. View

2.
Raphemot R, Rouhier M, Hopkins C, Gogliotti R, Lovell K, Hine R . Eliciting renal failure in mosquitoes with a small-molecule inhibitor of inward-rectifying potassium channels. PLoS One. 2013; 8(5):e64905. PMC: 3666979. DOI: 10.1371/journal.pone.0064905. View

3.
Weaver C, Harden D, Dworetzky S, Robertson B, Knox R . A thallium-sensitive, fluorescence-based assay for detecting and characterizing potassium channel modulators in mammalian cells. J Biomol Screen. 2005; 9(8):671-7. DOI: 10.1177/1087057104268749. View

4.
Bockenhauer D, Feather S, Stanescu H, Bandulik S, Zdebik A, Reichold M . Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ10 mutations. N Engl J Med. 2009; 360(19):1960-70. PMC: 3398803. DOI: 10.1056/NEJMoa0810276. View

5.
Lopez-Izquierdo A, Ponce-Balbuena D, Moreno-Galindo E, Arechiga-Figueroa I, Rodriguez-Martinez M, Ferrer T . The antimalarial drug mefloquine inhibits cardiac inward rectifier K+ channels: evidence for interference in PIP2-channel interaction. J Cardiovasc Pharmacol. 2011; 57(4):407-15. DOI: 10.1097/FJC.0b013e31820b7c03. View